COMMITMENTS AND CONTINGENCIES |
12 Months Ended |
|---|---|
Oct. 31, 2023 | |
| Commitments and Contingencies Disclosure [Abstract] | |
| COMMITMENTS AND CONTINGENCIES |
6. COMMITMENTS AND CONTINGENCIES
Litigation Matters
Other than lawsuits we bring to enforce our patent rights, we are not involved in any litigation or other legal proceedings and management is not aware of any pending litigation or legal proceeding against us that would have a material adverse effect upon our results of operations or financial condition.
License Commitments
As of October 31, 2023, our commitments under the license agreements with Wistar and Cleveland Clinic for the year ending October 31, 2024 were approximately $70,000.
Research & Development Agreements
We have entered into certain research and development agreements with various third-party vendors related to the manufacturing of materials necessary for the expected Phase 2 clinical trial of our breast cancer vaccine. As of October 31, 2023, future payments the Company may make under these agreements may be approximately $3.5 million and such payments may be made over up to a period.
|